Prednisolone pharmacokinetics in dogs with protein-losing enteropathy
Open Access
- 1 January 2025
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Veterinary Internal Medicine
- Vol. 39 (1) , e17277
Abstract
Background: It is unknown if glucocorticoid malabsorption contributes to the approximate 50% treatment failure rate in dogs with protein-losing enteropathy (PLE). Objective: To compare pharmacokinetics (PK) of orally administered prednisolone in dogs with PLE vs healthy controls. Animals: Fourteen dogs with well-characterized PLE and 7 control dogs. Methods: Prospective case-controlled study. Dogs were treated with 1 mg/kg prednisolone PO once daily for approximately 3 weeks. Venous blood samples were collected at set timepoints before and after prednisolone administration on the first (T1) and final (T2) study days. Total and non-protein bound serum prednisolone concentrations were determined using liquid chromatography tandem-mass spectrometry, and pharmacokinetics variables were derived from the drug concentration data. Pharmacokinetics variables were compared between PLE and control dogs and between PLE short-term responders and non-responders. Results: The PLE dogs had a shorter half-life of the terminal slope than control dogs (harmonic mean of 1.3 vs 1.8 hours; P = .05) whereas the percentage of serum prednisolone that was non-protein bound was higher in PLE dogs than in control dogs (median of 15.7% vs 6.7%; P = .02) at T1. Total prednisolone drug exposures and maximum total serum drug concentrations did not differ between PLE and control dogs at T1 or T2, nor did they differ between short-term responders and non-responders within the PLE population (P > .05 for all comparisons). Conclusions and Clinical Importance: Overall drug exposures are similar between PLE dogs and healthy controls. Glucocorticoid malabsorption is unlikely to be a common cause of treatment failure in dogs with PLE.Keywords
Funding Information
- Michigan State University College of Veterinary Medicine Endowed Research Funds, Specifically the Della K. Swander Fund
- Michigan State University College of Veterinary Medicine Trinket Fund
This publication has 52 references indexed in Scilit:
- Hematologic and serum biochemical effects of long-term administration of anti-inflammatory doses of prednisone in dogsAmerican Journal of Veterinary Research, 1992
- Pharmacokinetics of prednisolone in children with nephrosis.Archives of Disease in Childhood, 1990
- Effect of food on the absorption and pharmacokinetics of prednisolone from enteric-coated tabletsEuropean Journal of Clinical Pharmacology, 1989
- Prednisolone Binding to Plasma Proteins in Domestic SpeciesJournal of Pharmaceutical Sciences, 1988
- Prednisolone absorption in inflammatory bowel disease: correlation with anatomical site and extentAlimentary Pharmacology & Therapeutics, 1987
- LACK OF EFFECT OF SUCRALFATE ON PREDNISONE BIOAVAILABILITY1987
- NORMAL ABSORPTION OF ORAL PREDNISOLONE IN CHILDREN WITH ACTIVE INFLAMMATORY BOWEL-DISEASE, INCLUDING CASES WITH PROXIMAL TO DISTAL SMALL BOWEL INVOLVEMENT1985
- Altered Plasma Protein-Binding of Prednisolone in Patients With the Nephrotic SyndromeAmerican Journal of Kidney Diseases, 1984
- Effect of Food on the Bioavailability of PrednisoneThe Journal of Clinical Pharmacology, 1976
- PREDNISONE SIDE-EFFECTS AND SERUM-PROTEIN LEVELSThe Lancet, 1971